Results 31 to 40 of about 89 (85)

Cerebral Vein Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia [PDF]

Stroke, 2021
In the spring of 2021, reports of rare and unusual venous thrombosis in association with the ChAdOx1 and Ad26.COV2.S adenovirus-based coronavirus vaccines led to a brief suspension of their use by several countries. Thromboses in the cerebral and splanchnic veins among patients vaccinated in the preceding 4 weeks were described in 17 patients out of 7 ...
James E. Siegler, Piers Klein, Shadi Yaghi, Nicholas Vigilante, Mohamad Abdalkader, Jonathan M. Coutinho, Feras Abdul Khalek, Thanh N. Nguyen   +7 more
openaire   +2 more sources

Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis

Frontiers in Cardiovascular Medicine, 2022
Coronavirus disease 2019 (COVID-19) is a viral respiratory infection caused by the severe acute respiratory syndrome virus (SARS-CoV-2). Vaccines that protect against SARS-CoV-2 infection have been widely employed to reduce the incidence of symptomatic and severe disease.
Stefan D. Jevtic, Donald M. Arnold, Donald M. Arnold, Donald M. Arnold, Dimpy Modi, Dimpy Modi, Nikola Ivetic, Anna-Lise Bissola, Anna-Lise Bissola, Ishac Nazy, Ishac Nazy   +10 more
openaire   +3 more sources

Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia [PDF]

Canadian Medical Association Journal, 2021
[See related article at [www.cmaj.ca/lookup/doi/10.1503/cmaj.210795][2]][2] KEY POINTS In a related case report, Jones and colleagues describe a 63-year-old man who developed thromboses in his popliteal and pulmonary arteries.[1][2] The patient’s thromboses were likely caused by vaccine ...
Sholzberg, Michelle, Arnold, Donald M., Laupacis, Andreas   +2 more
openaire   +2 more sources

COVID-19 vaccine-induced immune thrombotic thrombocytopenia: a review

Clinical and Experimental Vaccine Research, 2023
Rare but serious thrombotic incidents in relation to thrombocytopenia, termed vaccine-induced immune thrombotic thrombocytopenia (VITT), have been observed since the vaccine rollout, particularly among replication-defective adenoviral vector-based severe acute respiratory syndrome coronavirus 2 vaccine recipients.
Siti Nur Atikah Aishah Suhaimi, Izzati Abdul Halim Zaki, Zakiah Mohd Noordin, Nur Sabiha Md Hussin, Long Chiau Ming, Hanis Hanum Zulkifly   +5 more
openaire   +2 more sources

Acute limb ischemia secondary to vaccine-induced thrombotic thrombocytopenia

Annals of Vascular Surgery - Brief Reports and Innovations, 2023
Vaccine-associated thrombosis has previously been described in patients presenting with cerebral sinus thrombosis, deep venous thrombosis/pulmonary embolism, or mesenteric venous thrombosis. Only recently has arterial thrombosis gained attention. A new entity known as vaccine-induced thrombotic thrombocytopenia (VITT) has been associated with the ...
Bowen Xie, Dana B. Semaan, Natalie D. Sridharan, Mohammad H. Eslami, Catherine Go   +4 more
openaire   +3 more sources

Vaccine-Induced Thrombotic Thrombocytopenia: A Case of Splanchnic Veins Thrombosis

Cureus, 2022
Vaccines have been vital in preventing and curbing the spread of SARS-CoV-2 infection. Adenoviral vector-based vaccines, namely the ChAdOx1-S vaccine (AstraZeneca, Cambridge, UK) and Ad26.COV2.S (Janssen; Johnson & Johnson, New Brunswick, NJ, USA), have been associated with a possibly fatal adverse event known as vaccine-induced thrombotic ...
Abbasi, Safwan, Alsermani, Anas, Alsegayyir, Abdulaziz, Altahan, Talal, Alsermani, Maamoun, Almustanyir, Sami   +5 more
openaire   +2 more sources

COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia: A Case Series

Cureus, 2021
Vaccine-induced thrombotic thrombocytopenia is a life-threatening prothrombotic syndrome that has been associated with two adenoviral vector-based coronavirus disease 2019 (COVID-19) vaccines. Although it remains a rare disorder with relatively low incidence, awareness of this condition is crucial given the ongoing vaccination programs of millions ...
Alalwan, Adel A, Abou Trabeh, Aissar, Premchandran, Divya, Razeem, Mohamed   +3 more
openaire   +2 more sources

The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia

Blood Advances, 2022
Abstract Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare but serious adverse syndrome occurring 5 to 30 days after adenoviral vector COVID-19 vaccination. Therefore, a practical evaluation of clinical assessments and laboratory testing for VITT is needed to prevent significant adverse outcomes as the global use of ...
Anna-Lise Bissola, Mercy Daka, Donald M. Arnold, James W. Smith, Jane C. Moore, Rumi Clare, Nikola Ivetic, John G. Kelton, Ishac Nazy   +8 more
openaire   +2 more sources

Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia

Viruses, 2022
Vaccine-induced thrombotic thrombocytopenia (VITT), or thrombosis with thrombocytopenia syndrome (TTS), is a rare but serious complication of adenovirus-based vaccines against severe respiratory syndrome coronavirus 2 (SARS-CoV-2). Observation of long-term outcomes is important to guide treatment of affected patients.
Victoria Panagiota, Christiane Dobbelstein, Sonja Werwitzke, Arnold Ganser, Nina Cooper, Ulrich J. Sachs, Andreas Tiede   +6 more
openaire   +3 more sources

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia

New England Journal of Medicine, 2021
The coronavirus disease 2019 (Covid-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stimulated the development of highly effective vaccines that were produced wi...
Cines, Douglas B., Bussel, James B.
openaire   +2 more sources